Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues.
about
Multiple advantageous amino acid variants in the NAT2 gene in human populationsArylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discoveryPharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Quantitative tissue and gene-specific differences and developmental changes in Nat1, Nat2, and Nat3 mRNA expression in the rat4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.Bioactivation of the human carcinogen aristolochic acidThe pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid.Variation in NAT2 acetylation phenotypes is associated with differences in food-producing subsistence modes and ecoregions in Africa.mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs.Computational and experimental analyses of mammalian arylamine N-acetyltransferase structure and function.Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements.Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and Functional characterization of a novel rNat3*2 genetic variant.Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations.Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancerSystemic functional expression of N-acetyltransferase polymorphism in the F344 Nat2 congenic rat.Update on the pharmacogenetics of NATs: structural considerations.Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.Extrahepatic metabolism at the body's internal-external interfaces.Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.Gene-environment interactions in esophageal cancer.Role of human sulfotransferase 1A1 and N-acetyltransferase 2 in the metabolic activation of 16 heterocyclic amines and related heterocyclics to genotoxicants in recombinant V79 cells.Xenobiotic metabolizing enzyme activities in cells used for testing skin sensitization in vitro.Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes.A long-lived luminescent probe to sensitively detect arylamine N-acetyltransferase (NAT) activity of cells.Cloning and characterization of the rat lysyl oxidase gene promoter: identification of core promoter elements and functional nuclear factor I-binding sites.Simulation of chemical metabolism for fate and hazard assessment. V. Mammalian hazard assessment.Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype.A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions.Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
P2860
Q21144240-AC750590-8721-4D45-9D40-9B547CC36961Q26995125-1C7059F7-853A-4E24-A235-C900C96553C6Q27011622-7CEECD7B-5565-4D15-8500-1C9B44AF3310Q28583635-F6BD6490-82B1-4B2E-A43A-28CEC4AD6965Q29347040-9A3E0368-8F89-4686-BA94-0A2F8D3BA26CQ34009989-1B059C6C-00C1-4421-9C18-B9628445C06EQ35238140-4E3D9461-76AA-4EB5-8478-752836B0EB6AQ35856283-22CA69E9-6317-4CF7-AB96-1281EFAE39D2Q35990861-D33F814E-0E55-4F42-98E1-52B1B0F481FDQ36158467-F1224664-64B6-4B8E-AECF-A75DDFCC217AQ36158490-D71B4B09-FAE8-4B0F-A024-AAE074D0D3CFQ36168750-C0FA59DA-E109-474A-8159-4526EC5542D6Q36301606-A4B19354-D4B1-4C51-B4FB-666330F5AF8FQ36743654-37295F9D-E079-492D-9A8B-34792F65F5CBQ37000797-C0FA308A-9FA6-481E-8BCF-BCB7988290DCQ37329162-7F411170-94BF-46F2-8D99-E74093F4FD00Q37457764-20E6EE5E-9834-4A16-995C-5CCEB5F21F98Q37698414-194BB155-EA21-40D4-B8DE-B3AEC91357CBQ38199198-58014CD9-E33F-43D3-AC8D-0675DD33DE9DQ38357424-336DC221-448F-4D88-904F-88676A19EC41Q38556530-C15C0AD3-2F19-4315-9079-EDD45784A75BQ38979808-80461D23-0947-4D29-A8E1-C1467FBF7DCCQ39108182-49897656-85DB-478F-94D0-DF4D1F7FA3CBQ39259079-CE85ED7F-939D-4631-B780-636CB5BF1711Q39410980-93103676-C5DF-47F5-BC3C-566D2D00D476Q40114338-B7485743-61FA-41B1-8088-ED4787E0C081Q46109800-F9C302B5-C809-4653-8ECC-50D630000037Q47636095-5BC7B6A1-DD72-40E3-8644-0A3DA49BD94CQ54428505-9EFB21FD-4535-48E4-881E-D210CC22771BQ55503255-E30EC2F4-4333-4D76-BB48-F1AC5DD4BCD9
P2860
Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Identification of N-acetyltran ...... pecific mRNA in human tissues.
@ast
Identification of N-acetyltran ...... pecific mRNA in human tissues.
@en
type
label
Identification of N-acetyltran ...... pecific mRNA in human tissues.
@ast
Identification of N-acetyltran ...... pecific mRNA in human tissues.
@en
prefLabel
Identification of N-acetyltran ...... pecific mRNA in human tissues.
@ast
Identification of N-acetyltran ...... pecific mRNA in human tissues.
@en
P2093
P2860
P356
P1476
Identification of N-acetyltran ...... specific mRNA in human tissues
@en
P2093
Anwar Husain
David F Barker
Mark A Doll
Xiaoyan Zhang
P2860
P304
P356
10.1124/DMD.106.014621
P577
2007-02-07T00:00:00Z